-transparent.png){kind=logo}
The influence of CGS 21680, an adenosine A2A receptor agonist, on striatal glutamate extracellular levels was tested in a microdialysis study in rats. CGS 21680 (10 mu M), infused intrastriatally through the microdialysis probe, greatly enhanced glutamate extracellular levels. These results show that striatal adenosine A2A receptors are involved in the regulation of striatal glutamate extracellular levels. They also suggest that adenosine A2A receptor antagonists may possess neuroprotective effects in models of striatal excitotoxicity.
Related Publications
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
March 2003,
European journal of pharmacology,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
August 2000,
Neuroreport,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
March 2016,
Journal of neurochemistry,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
February 2001,
Life sciences,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
April 2014,
Journal of psychiatric research,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
March 2016,
Journal of neurochemistry,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
February 2021,
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
October 2009,
Psychopharmacology,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
January 2012,
Neurobiology of disease,
P Popoli, and
P Betto, and
R Reggio, and
G Ricciarello
April 2018,
Genes, brain, and behavior,
